Pharma Grade Cellulose Powder Market Report 2026

Pharma Grade Cellulose Powder Market Overview

• Pharma Grade Cellulose Powder market size has reached to $1.55 billion in 2025 • Expected to grow to $2.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.1% • Growth Driver: The Rising Pharmaceutical Production Fueling The Growth Of The Market Due To Increasing Healthcare Demand • Market Trend: Expansion Of Microcrystalline Cellulose Production Facilities To Strengthen Pharmaceutical Supply Chains • North America was the largest region in 2025.

What Is Covered Under Pharma Grade Cellulose Powder Market?

Pharma grade cellulose powder is a refined, plant-based material designed to meet stringent pharmaceutical quality standards. It is commonly used as an excipient in drug formulations. Its chemically inert, non-toxic, and stable properties ensure compatibility with active pharmaceutical ingredients (APIs). It also enhances the uniformity and production efficiency of oral solid dosage forms. The main product types of pharma grade cellulose powder are microcrystalline cellulose (MCC), carboxymethyl cellulose (CMC), hydroxypropyl methylcellulose (HPMC), and hydroxypropyl cellulose (HPC). Microcrystalline cellulose (MCC) is a stable, compressible wood pulp derivative widely used in pharmaceuticals as a binder, filler, and disintegrant due to its excellent flow and direct compression properties. It shows various functionalities such as binding agent, thickening agent, stabilizer, disintegrant, coating agent for several applications including pharmaceuticals, nutraceuticals, cosmetics, and others, and is used by various end-users such as contract research organizations (CROs), pharmaceutical and biotechnology companies, academic and research institutions, manufacturers of dietary supplements, and food and beverage industries.

What Is The Pharma Grade Cellulose Powder Market Growth Forecast?

The pharma grade cellulose powder market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to growth in nutraceutical applications, rising demand for clean-label excipients, expansion of generic drug pipelines, advancements in excipient engineering, increasing sustainability requirements. Major trends in the forecast period include rising demand for plant-based pharmaceutical excipients, increasing use in solid oral dosage forms, growing adoption of microcrystalline cellulose, expansion of multi-functional cellulose excipients, increasing focus on sustainable excipient sourcing.

Global Pharma Grade Cellulose Powder Market Segmentation

1) By Product Type: Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Hydroxypropyl Methylcellulose (HPMC), Hydroxypropyl Cellulose (HPC) 2) By Functionality: Binding Agent, Thickening Agent, Stabilizer, Disintegrant, Coating Agent 3) By Application: Pharmaceuticals, Nutraceuticals, Cosmetics, Other Applications 4) By End-User: Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic And Research Institutions, Manufacturers Of Dietary Supplements, Food And Beverage Industries Subsegments: 1) By Microcrystalline Cellulose: Powder, Granules 2) By Carboxymethyl Cellulose (CMC): Sodium Carboxymethyl Cellulose (CMC), Calcium Carboxymethyl Cellulose (CMC), Other Carboxymethyl Cellulose (CMC) Variants 3) By Hydroxypropyl Methylcellulose (HPMC): Low Viscosity Hydroxypropyl Methylcellulose (HPMC), Medium Viscosity Hydroxypropyl Methylcellulose (HPMC), High Viscosity Hydroxypropyl Methylcellulose (HPMC) 4) By Hydroxypropyl Cellulose: Low Substitution Hydroxypropyl Cellulose (HPC), High Substitution Hydroxypropyl Cellulose (HPC)

What Is The Driver Of The Pharma Grade Cellulose Powder Market?

The rising pharmaceutical production is expected to propel the growth of the pharma-grade cellulose powder market going forward. Pharmaceutical production involves manufacturing medicines by formulating, synthesizing, and quality-controlling active ingredients and excipients to ensure safety, effectiveness, and regulatory compliance. Pharmaceutical production is increasing due to the rise in chronic diseases, which require continuous and long-term medication for effective management. Pharma-grade cellulose powder supports pharmaceutical production by functioning as a dependable binder, filler, and stabilizer, helping maintain tablet integrity and ensure uniform drug distribution. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association that represents the pharmaceutical industry in Europe, the total pharmaceutical production in Europe accounted for $422,803 million (€390,000 million) in 2023, up from $393,857 million (€363,300 million) in 2022. Therefore, the rising pharmaceutical production is driving the growth of the pharma-grade cellulose powder market.

Key Players In The Global Pharma Grade Cellulose Powder Market

Major companies operating in the pharma grade cellulose powder market are Roquette Frères, Ashland Global, JRS Pharma, DFE Pharma, Sigachi Industries Ltd., Accent Microcell Ltd., FMC Corporation, Dow Chemical Company, Shin-Etsu Chemical Co. Ltd., Colorcon, Nippon Paper Industries Co. Ltd., Rayonier Advanced Materials, Lotte Fine Chemical, Mingtai Chemical Co. Ltd., Weifang Lude Chemical Co. Ltd., Shandong Head Co. Ltd., Zhejiang Kehong Chemical Co. Ltd., Anhui Sunhere Pharmaceutical Excipients Co. Ltd., Maple Biotech Pvt. Ltd., Ankit Pulps & Boards Pvt. Ltd.

Global Pharma Grade Cellulose Powder Market Trends and Insights

Major companies operating in the pharma-grade cellulose powder market are focused on developing a new microcrystalline cellulose facility to expand production capacity and strengthen their supply chain capabilities for pharmaceutical excipients. A microcrystalline cellulose facility is a dedicated plant where purified cellulose undergoes controlled chemical and mechanical treatments to produce uniform, fine-grade particles for pharmaceutical use. For instance, in September 2023, Nitika Pharmaceuticals Specialties, an India-based excipient manufacturing company, inaugurated Tabcell, India’s largest microcrystalline cellulose (MCC) manufacturing plant at Nagpur. The plant, equipped with cutting-edge technology and an installed capacity of 1200 metric tons, was inaugurated by Union Minister Nitin Gadkari and is a significant milestone under the Government of India’s Production Linked Incentive (PLI) scheme for excipients. This new plant strengthens Nitika Pharma’s position as a global leader in pharmaceutical excipients, supporting both domestic needs and exports to over 92 countries, while also contributing to the “Make in India” initiative and generating substantial local employment opportunities.

What Are Latest Mergers And Acquisitions In The Pharma Grade Cellulose Powder Market?

In December 2024, Nordic Bioproducts Group, a Finland-based manufacturer of microcrystalline cellulose (MCC), partnered with C.Q. Massó to expand the supply of sustainable microcrystalline cellulose (MCC) for the beauty and personal care industries. This partnership aims to help manufacturers comply with evolving EU regulations on harmful ingredients and product traceability by providing MCC, a renewable, wood-derived alternative to substances such as talc and titanium dioxide, and thereby supporting the industry’s shift toward safer, more environmentally responsible formulations and ensuring a reliable, traceable supply chain across Europe. C.Q. Massó is a Spain-based company that manufactures chemical specialties across various sectors.

Regional Insights

North America was the largest region in the pharma-grade cellulose powder market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharma Grade Cellulose Powder Market?

The pharma-grade cellulose powder market consists of sales of sodium carboxymethyl cellulose and cellulose acetate phthalate. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharma Grade Cellulose Powder Market Report 2026?

The pharma grade cellulose powder market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharma grade cellulose powder industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.